Stock fall on Tuesday

Stocks dipped on Tuesday as investors tried to sustain a resurgence after weeks of losses.

The Dow Jones Industrial Average dropped 172 points, or 0.5 percent, on Wednesday. The S&P 500 fell 1.4 percent, while the Nasdaq Composite fell 2.7 percent.

Snap’s stock dropped more than 36% after the firm warned that it expects to fail profit and revenue forecasts in the current quarter and that hiring will stall. Snap’s stock dropped 6%, while Meta Platforms’ stock dropped 17 percent.

Advertisements

“Stocks are taking a beating this morning, and the major culprit is the Snap warning from Monday evening,” writes Vital Knowledge’s Adam Crisafulli. “Some may be skeptical that a small, always unprofitable ephemeral social networking startup can take down the entire tape, but considering how sensitive this tape is, SNAP punches far above its weight.”

“Tech continues to dominate the market, both statistically (it still has the largest weighting) and psychologically, and despite intense liquidation in recent months, people still own a lot of it,” he noted.

Snap’s stock fell alongside that of other major tech companies. Alphabet and Netflix both fell by nearly 6%. Amazon was down 3%, while Apple was down more than 1%.

After Snap’s warning, Morgan Stanley analysts stated, “We expect all online ad platforms to face some impact of a large consumer pullback.” “Advertising follows a cycle.”

This week’s retail earnings will continue, and investors will be watching to see how rising inflation affects consumer demand. They also want to hear if last week’s big-box store disappointments were unique to that business or reflected across the industry.

Abercrombie & Fitch’s stock plunged 27% on Tuesday after the company reported that freight and product expenses dragged on sales in the fiscal first quarter. Best Buy’s stock jumped after the business reported a mixed quarter, but it ended the day down less than 1%. During Monday’s relief surge, retailers were among the top gainers in the S&P 500.

The developments come a day after the market recovered from last week’s sharp sell-off, which saw the Dow hit an eight-week losing run for the first time since 1923 and the S&P 500 briefly enter bear market territory on an intraday basis.

Following a week of steep losses, stocks surged Monday, with the Dow jumping 618 points, or about 2%. The S&P 500 increased by 1.9 percent, while the Nasdaq Composite increased by 1.6 percent. Investors are wondering if the rebound will last or if it is just another brief relief rally amid the persistent sell-off that has yet to strike a bottom.

“This kind of climate with the whipsaw and such large ups and downs is a trading environment where it might feel like you were wrong yesterday on any given day, and that is ripe for mistakes,” Liz Young, Sofi’s head of investment strategy, told CNBC’s “Closing Bell: Overtime.”

New home sales and Fed Chair Jerome Powell’s address at the National Center for American Indian Enterprise Development summit on Tuesday are attracting investors’ attention. After the bell, Nordstrom and Urban Outfitters will announce earnings.

CLOV Achieves 121.60% Quarterly Revenue Growth

The CLOV stock price fluctuated between $2.41 and $2.62 throughout the trading session with the volume trading being 11M shares, which represented a negative variation when compared to the three months average volume of 13M shares.

The share price of Clover Health Investments, Corp. (NasdaqGS:CLOV) dipped -10.41% to close Monday’s market session at $2.41, lower as compared to yesterday’s close which brings the market valuation of the company to $1.34B.

The 52-week high for the Clover Health Investments, Corp.’s shares is $28.8500. That puts it -91.65% from that peak with a 52-week low of $1.9500, while the S&P 500’s share price change was of -3.87%.

What does the trading volume tell us about the CLOV stock?

During the last trading session, Clover Health Investments, Corp. (NasdaqGS:CLOV) has seen decay in its daily volume. The daily volume was of 11M, while in the last 10 days the average was 6.17M and last three months – 12.74M.

Shrinking short interest

The Clover Health Investments, Corp.’s shares are seeing a decreasing short interest compared to the previous month. As of today, there are 29.15M shares being shorted which translates into 2.97 of a short ratio for CLOV, while in the previous month the shorted shares were 32.84M.

Clover Health Investments, Corp.’s (NasdaqGS:CLOV) financials

With a market cap of 1.34B, Clover Health Investments, Corp. holds a total cash of $615.25M that translates into $1.3 per share, while the total debt is of $27.83M.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 121.60%. The current revenue is of $1.36B that is $3.30 per share.

This is a great sign for a bright future.

TSLA Shares Now Trade at 117.46 P/E

During the last session 30M of Tesla, Inc. (NasdaqGS:TSLA)’s shares were traded. The stock closed at $787.11 per share indicating that it lost -$78.54 or -9.07% during that day which brings the Tesla, Inc.’s valuation to $896.82B.

The 52-week high for the Tesla, Inc.’s shares is $1,243.49. This is the highest price the TSLA shares have gotten with a great gain of 27.53% since the share price dropped to a 52-week low of $546.98.

The company currently has a 117.46 P/E ratio and a price target of $993.82.

What does the trading volume tell us about the TSLA stock?

During the last trading session, Tesla, Inc. (NasdaqGS:TSLA) has seen growth in its daily volume. The daily volume was of 30M, while in the last 10 days the average was 30.1M and last three months – 25.53M.

Shrinking short interest

The Tesla, Inc.’s shares are seeing a decreasing short interest compared to the previous month. As of today, there are 24.55M shares being shorted which translates into 0.99 of a short ratio for TSLA, while in the previous month the shorted shares were 25.15M.

Tesla, Inc. (NasdaqGS:TSLA)’s financials

With a market cap of 896.82B, Tesla, Inc. holds a total cash of $18.01B that translates into $17.39 per share, while the total debt is of $7.02B.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 80.50%. The current revenue is of $62.19B that is $61.93 per share.

This is a great sign for a bright future.

XOM Hits 329.54B Market Cap

The XOM stock price fluctuated between $85.43 and $91.5 throughout the trading session with the volume trading being 71M shares, which represented a positive variation when compared to the three months average volume of 29M shares.

The share price of Exxon Mobil Corporation (NYSE:XOM) ran up 0.76% to close Tuesday’s market session at $87.78, higher as compared to yesterday’s close which brings the market valuation of the company to $329.54B.

The 52-week high for the Exxon Mobil Corporation’s shares is $91.50. That puts it -4.07% from that peak with a 52-week low of $52.10, while the S&P 500’s share price change was of 7.75%.

The company currently has a 14.44 P/E ratio and a price target of $84.29.

What does the trading volume tell us about the XOM stock?

During the last trading session, Exxon Mobil Corporation (NYSE:XOM) has seen growth in its daily volume. The daily volume was of 71M, while in the last 10 days the average was 38.05M and last three months – 29.26M.

Growing short interest

The Exxon Mobil Corporation’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 48.52M shares being shorted which translates into 1.41 of a short ratio for XOM, while in the previous month the shorted shares were 43.24M.

Exxon Mobil Corporation’s (NYSE:XOM) financials

With a market cap of 329.54B, Exxon Mobil Corporation holds a total cash of $6.8B that translates into $1.61 per share, while the total debt is of $53.03B.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 79.40%. The current revenue is of $278.98B that is $65.26 per share.

This is a great sign for a bright future.

FB Keeps On Delivering

During the last session 38M of Meta Platforms, Inc. (NasdaqGS:FB)’s shares were traded. The stock closed at $190.29 per share indicating that it gained $2.82 or 1.5% during that day which brings the Meta Platforms, Inc.’s valuation to $572.91B.

The 52-week high for the Meta Platforms, Inc.’s shares is $384.33. That puts it -50.49% from that peak with a 52-week low of $186.11, while the S&P 500’s share price change was of 7.75%.

The company currently has a 15.29 P/E ratio and a price target of $326.9.

What does the trading volume tell us about the FB stock?

During the last trading session, Meta Platforms, Inc. (NasdaqGS:FB) has seen growth in its daily volume. The daily volume was of 38M, while in the last 10 days the average was 36.06M and last three months – 33.69M.

Growing short interest

The Meta Platforms, Inc.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 31.82M shares being shorted which translates into 0.64 of a short ratio for FB, while in the previous month the shorted shares were 24.11M.

Meta Platforms, Inc. (NasdaqGS:FB)’s financials

With a market cap of 572.91B, Meta Platforms, Inc. holds a total cash of $48B that translates into $17.63 per share, while the total debt is of $14.45B.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 19.90%. The current revenue is of $117.93B that is $41.89 per share.

This is a great sign for a bright future.

CLOV Looks Promising in Analysts’ Eyes

Advertisements

During the last session, 43M of Clover Health Investments, Corp. (NasdaqGS:CLOV)’s shares were traded. The stock closed at $2.99 per share indicating that it gained $0.39 or 15% during that day which brings the Clover Health Investments, Corp.’s valuation to $1.19B.

The 52-week high for the Clover Health Investments, Corp.’s shares is $28.85. That puts it -89.64% from that peak with a 52-week low of $1.9500, while the S&P 500’s share price change was 7.75%.

What does the trading volume tell us about the CLOV stock?

During the last trading session, Clover Health Investments, Corp. (NasdaqGS:CLOV) has seen growth in its daily volume. The daily volume was of 43M, while in the last 10 days the average was 23.89M and last three months – 14.85M.

Growing short interest

The Clover Health Investments, Corp.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 33.98M shares being shorted which translates into 2.59 of a short ratio for CLOV, while in the previous month the shorted shares were 26.25M.

Clover Health Investments, Corp. (NasdaqGS:CLOV)’s financials

With a market cap of 1.19B, Clover Health Investments, Corp. holds a total cash of $615.25M that translates into $1.3 per share, while the total debt is of $27.83M.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 121.60%. The current revenue is of $1.36B that is $3.30 per share.

This is a great sign for a bright future.

CLOV: Opportunities Keep Arising

During the last session 34M of Clover Health Investments, Corp. (NasdaqGS:CLOV)’s shares were traded. The stock closed at $2.01 per share indicating that it lost -$0.03 or -1.47% during that day which brings the Clover Health Investments, Corp.’s valuation to $993.50M.

The 52-week high for the Clover Health Investments, Corp.’s shares is $28.8500. That puts it -93.03% from that peak with a 52-week low of $1.9500, while the S&P 500’s share price change was of 10.35%.

What does the trading volume tell us about the CLOV stock?

During the last trading session, Clover Health Investments, Corp. (NasdaqGS:CLOV) has seen growth in its daily volume. The daily volume was of 34M, while in the last 10 days the average was 15.55M and last three months – 14.26M.

Growing short interest

The Clover Health Investments, Corp.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 27.95M shares being shorted which translates into 2.07 of a short ratio for CLOV, while in the previous month the shorted shares were 24.7M.

Clover Health Investments, Corp. (NasdaqGS:CLOV)’s financials

With a market cap of 993.50M, Clover Health Investments, Corp. holds a total cash of $442.1M that translates into $1.05 per share, while the total debt is of $28.48M.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 139.30%. The current revenue is of $1.16B that is $4.07 per share.

This is a great sign for a bright future.

GME Sees a 32.52% 52-Week Change

During the last session 2M of GameStop Corp. (NYSE:GME)’s shares were traded. The stock closed at $118.06 per share indicating that it lost -$3.47 or -2.86% during that day which brings the GameStop Corp.’s valuation to $9.28B.

The 52-week high for the GameStop Corp.’s shares is $348.50. That puts it -66.12% from that peak with a 52-week low of $44.70, while the S&P 500’s share price change was of 10.79%.

What does the trading volume tell us about the GME stock?

During the last trading session, GameStop Corp. (NYSE:GME) has seen decay in its daily volume. The daily volume was of 2M, while in the last 10 days the average was 2.65M and last three months – 3.12M.

Growing short interest

The GameStop Corp.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 11M shares being shorted which translates into 2.68 of a short ratio for GME, while in the previous month the shorted shares were 8.45M.

GameStop Corp. (NYSE:GME)’s financials

With a market cap of 9.28B, GameStop Corp. holds a total cash of $1.41B that translates into $18.6 per share, while the total debt is of $667.8M.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 29.10%. The current revenue is of $5.88B that is $84.04 per share.

This is a great sign for a bright future.

Innovation? PLTR

The PLTR stock price fluctuated between $10.3 and $11.19 throughout the trading session with the volume trading being 104M shares, which represented a positive variation when compared to the three months average volume of 47M shares.

The share price of Palantir Technologies Inc. (NYSE:PLTR) dipped -4.9% to close Tuesday’s market session at $10.48, lower as compared to yesterday’s close which brings the market valuation of the company to $22.09B.

The 52-week high for the Palantir Technologies Inc.’s shares is $29.29. That puts it -64.22% from that peak with a 52-week low of $10.30, while the S&P 500’s share price change was of 10.79%.

What does the trading volume tell us about the PLTR stock?

During the last trading session, Palantir Technologies Inc. (NYSE:PLTR) has seen growth in its daily volume. The daily volume was of 104M, while in the last 10 days the average was 63.08M and last three months – 46.57M.

Growing short interest

The Palantir Technologies Inc.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 114.12M shares being shorted which translates into 2.22 of a short ratio for PLTR, while in the previous month the shorted shares were 102.09M.

Palantir Technologies Inc.’s (NYSE:PLTR) financials

With a market cap of 22.09B, Palantir Technologies Inc. holds a total cash of $2.52B that translates into $1.25 per share, while the total debt is of $260.07M.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 34.40%. The current revenue is of $1.54B that is $0.80 per share.

This is a great sign for a bright future.

BABA Sees a Decrease in Volume

During the last session 21M of Alibaba Group Holding Limited (NYSE:BABA)’s shares were traded. The stock closed at $118.99 per share indicating that it lost -$5.44 or -4.37% during that day which brings the Alibaba Group Holding Limited’s valuation to $332.28B.

The 52-week high for the Alibaba Group Holding Limited’s shares is $254.90. That puts it -53.32% from that peak with a 52-week low of $108.70, while the S&P 500’s share price change was of 12.04%.

The company currently has a 16.68 P/E ratio and a price target of $200.02.

What does the trading volume tell us about the BABA stock?

During the last trading session, Alibaba Group Holding Limited (NYSE:BABA) has seen decay in its daily volume. The daily volume was of 21M, while in the last 10 days the average was 18.2M and last three months – 23.43M.

Shrinking short interest

The Alibaba Group Holding Limited’s shares are seeing a decreasing short interest compared to the previous month. As of today, there are 47.18M shares being shorted which translates into 1.92 of a short ratio for BABA, while in the previous month the shorted shares were 54.05M.

Alibaba Group Holding Limited (NYSE:BABA)’s financials

With a market cap of 332.28B, Alibaba Group Holding Limited holds a total cash of $459.2B that translates into $170.38 per share, while the total debt is of $183.16B.

The company has seen an increase in the revenue with a year-over-year quarterly revenue growth percentage of 29.40%. The current revenue is of $814.91B that is $301.09 per share.

This is a great sign for a bright future.